THOMAS MONATH to Vaccinia virus
This is a "connection" page, showing publications THOMAS MONATH has written about Vaccinia virus.
Connection Strength
1.090
-
Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax in healthy vaccinia-naive adults. Vaccine. 2009 Mar 04; 27(10):1637-44.
Score: 0.311
-
Lack of transmission of vaccinia virus. Emerg Infect Dis. 2006 Apr; 12(4):698-700.
Score: 0.258
-
ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain)--a second-generation smallpox vaccine for biological defense. Int J Infect Dis. 2004 Oct; 8 Suppl 2:S31-44.
Score: 0.233
-
Clonal vaccinia virus grown in cell culture as a new smallpox vaccine. Nat Med. 2003 Sep; 9(9):1125-30.
Score: 0.215
-
Development of a novel vaccinia-neutralization assay based on reporter-gene expression. J Infect Dis. 2003 Aug 01; 188(3):440-8.
Score: 0.053
-
Flow-cytometric detection of vaccinia-induced memory effector CD4(+), CD8(+), and gamma delta TCR(+) T cells capable of antigen-specific expansion and effector functions. J Infect Dis. 2005 Oct 15; 192(8):1362-71.
Score: 0.016
-
Dengue 2 virus envelope protein expressed by a recombinant vaccinia virus fails to protect monkeys against dengue. J Gen Virol. 1988 Aug; 69 ( Pt 8):1921-9.
Score: 0.005